The basis of bone tissue quality impairment is calcium imbalance. To correct calcium-deficient states, the priority is to ensure an adequate supply of calcium and vitamins to the body, which contribute to its assimilation and entry into bone tissue. In this context, new products that have recently appeared on pharmaceutical market of Ukraine attract an attention: OSTEOCITRATE – a vitamin K2-enhanced complex of calcium citrate, vitamin D3 and collagen-forming minerals for the prevention of osteoporosis, as well as OSTEOCITRATE MAX - for the treatment of osteoporosis and fractures without risk for kidneys and blood vessels.